While the drugs have grown in popularity among doctors and patients, they are generally too expensive for most people to ...

Experts share why a diet rich in plant-based, nutrient-dense foods is key to staying healthy when using medications that curb ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...

The lower rating came from HSBC, which cited too much optimism around its new weight-loss pill, and the strength of Novo ...

HSBC analyst warns of a downside in Eli Lilly stock to $700. Rajesh Kumar cited 'valuation' as his number 1 concern.

All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...

The weight-loss drugs have grown in popularity, but are generally too expensive for most people to afford without insurance ...

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

The Lessie B. Price Center advertised their fitness programs for seniors and educational programs for youth at their open ...

The Columbia County Spring Fair is back in town, but this time with some policy changes amid disruptions last week.